Stay updated on Lumateperone Monotherapy in Bipolar/Major Depressive Disorder Clinical Trial

Sign up to get notified when there's something new on the Lumateperone Monotherapy in Bipolar/Major Depressive Disorder Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lumateperone Monotherapy in Bipolar/Major Depressive Disorder Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page update reflects a version revision to v3.4.2 and the removal of a government funding status notice; these are housekeeping updates that do not affect the clinical trial details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T11:37:40.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Added a government funding notice about potential delays and site status. Updated the page revision to v3.4.1 and removed the previous v3.4.0 tag.
    Difference
    0.3%
    Check dated 2026-02-04T10:20:37.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now includes a 'Show glossary' option and updated QC-related labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with a new site revision 'Revision: v3.4.0' replacing the previous version.
    Difference
    0.2%
    Check dated 2026-01-28T06:15:02.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page now displays the system revision label 'Revision: v3.3.4' replacing the previous 'Revision: v3.3.3'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:08:01.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Location information has been reorganized under a unified 'Locations' section listing the states (California, Florida, Georgia, Missouri, New York, North Carolina, Washington). The separate state-location blocks were removed and the 'HHS Vulnerability Disclosure' footer link was deleted.
    Difference
    0.7%
    Check dated 2025-12-23T10:21:50.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.3.2, replacing Revision: v3.3.1.
    Difference
    0.0%
    Check dated 2025-12-01T17:41:25.000Z thumbnail image

Stay in the know with updates to Lumateperone Monotherapy in Bipolar/Major Depressive Disorder Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lumateperone Monotherapy in Bipolar/Major Depressive Disorder Clinical Trial page.